Skip to main content
SpringerLink
Log in

Fungizone (amphotericin B) labelling is being revised in the UK to warn of the risks of overdose

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. MHRA.Parenteral amphotericin B: fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations. Drug Safety Update 3: 8, No. 9, Apr 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fungizone (amphotericin B) labelling is being revised in the UK to warn of the risks of overdose. React. Wkly. 1298, 5 (2010). https://doi.org/10.2165/00128415-201012980-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012980-00010

Keywords

Search

Navigation